These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 20095149)

  • 21. A single immunization with a minute dose of a lentiviral vector-based vaccine is highly effective at eliciting protective humoral immunity against West Nile virus.
    Iglesias MC; Frenkiel MP; Mollier K; Souque P; Despres P; Charneau P
    J Gene Med; 2006 Mar; 8(3):265-74. PubMed ID: 16308885
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glycosylation of the envelope protein of West Nile Virus affects its replication in chicks.
    Totani M; Yoshii K; Kariwa H; Takashima I
    Avian Dis; 2011 Dec; 55(4):561-8. PubMed ID: 22312974
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Vaccine-induced protection of rhesus macaques against plasma viremia after intradermal infection with a European lineage 1 strain of West Nile virus.
    Verstrepen BE; Oostermeijer H; Fagrouch Z; van Heteren M; Niphuis H; Haaksma T; Kondova I; Bogers WM; de Filette M; Sanders N; Stertman L; Magnusson S; Lőrincz O; Lisziewicz J; Barzon L; Palù G; Diamond MS; Chabierski S; Ulbert S; Verschoor EJ
    PLoS One; 2014; 9(11):e112568. PubMed ID: 25392925
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Live-attenuated recombinant equine herpesvirus type 1 (EHV-1) induces a neutralizing antibody response against West Nile virus (WNV).
    Rosas CT; Tischer BK; Perkins GA; Wagner B; Goodman LB; Osterrieder N
    Virus Res; 2007 Apr; 125(1):69-78. PubMed ID: 17241683
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A West Nile virus recombinant protein vaccine that coactivates innate and adaptive immunity.
    McDonald WF; Huleatt JW; Foellmer HG; Hewitt D; Tang J; Desai P; Price A; Jacobs A; Takahashi VN; Huang Y; Nakaar V; Alexopoulou L; Fikrig E; Powell TJ
    J Infect Dis; 2007 Jun; 195(11):1607-17. PubMed ID: 17471430
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.
    Siger L; Bowen R; Karaca K; Murray M; Jagannatha S; Echols B; Nordgren R; Minke JM
    Vet Ther; 2006; 7(3):249-56. PubMed ID: 17039448
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protective efficacy of a recombinant subunit West Nile virus vaccine in domestic geese (Anser anser).
    Jarvi SI; Lieberman MM; Hofmeister E; Nerurkar VR; Wong T; Weeks-Levy C
    Vaccine; 2008 Oct; 26(42):5338-44. PubMed ID: 18723064
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.
    Siger L; Bowen RA; Karaca K; Murray MJ; Gordy PW; Loosmore SM; Audonnet JC; Nordgren RM; Minke JM
    Am J Vet Res; 2004 Nov; 65(11):1459-62. PubMed ID: 15566080
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Live measles vaccine expressing the secreted form of the West Nile virus envelope glycoprotein protects against West Nile virus encephalitis.
    Desprès P; Combredet C; Frenkiel MP; Lorin C; Brahic M; Tangy F
    J Infect Dis; 2005 Jan; 191(2):207-14. PubMed ID: 15609230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A new competitive ELISA detects West Nile virus infection using monoclonal antibodies against the precursor-membrane protein of West Nile virus.
    Hirota J; Shimizu S
    J Virol Methods; 2013 Mar; 188(1-2):132-8. PubMed ID: 23266257
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical and acquired immunologic responses to West Nile virus infection of domestic chickens (Gallus gallus domesticus).
    Fair JM; Nemeth NM; Taylor-McCabe KJ; Shou Y; Marrone BL
    Poult Sci; 2011 Feb; 90(2):328-36. PubMed ID: 21248329
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Measles vaccine expressing the secreted form of West Nile virus envelope glycoprotein induces protective immunity in squirrel monkeys, a new model of West Nile virus infection.
    Brandler S; Marianneau P; Loth P; Lacôte S; Combredet C; Frenkiel MP; Desprès P; Contamin H; Tangy F
    J Infect Dis; 2012 Jul; 206(2):212-9. PubMed ID: 22551814
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Persistence of antibodies to West Nile virus nonstructural protein 5.
    Prince HE; Lapé-Nixon M; Yeh C; Tobler LH; Busch MP
    J Clin Virol; 2008 Sep; 43(1):102-6. PubMed ID: 18467165
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant FAdV-4 fiber-2 protein protects chickens against hepatitis-hydropericardium syndrome (HHS).
    Schachner A; Marek A; Jaskulska B; Bilic I; Hess M
    Vaccine; 2014 Feb; 32(9):1086-92. PubMed ID: 24397897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunogenicity and protective efficacy of a recombinant subunit West Nile virus vaccine in rhesus monkeys.
    Lieberman MM; Nerurkar VR; Luo H; Cropp B; Carrion R; de la Garza M; Coller BA; Clements D; Ogata S; Wong T; Martyak T; Weeks-Levy C
    Clin Vaccine Immunol; 2009 Sep; 16(9):1332-7. PubMed ID: 19641099
    [TBL] [Abstract][Full Text] [Related]  

  • 36. WEST NILE VIRUS SEROCONVERSION IN EASTERN LOGGERHEAD SHRIKE (
    Schutten K; Chabot A; Wheeler H
    J Zoo Wildl Med; 2021 Apr; 52(1):185-191. PubMed ID: 33827175
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Enzyme-linked immunosorbent assays using recombinant envelope protein expressed in COS-1 and Drosophila S2 cells for detection of West Nile virus immunoglobulin M in serum or cerebrospinal fluid.
    Muerhoff AS; Dawson GJ; Dille B; Gutierrez R; Leary TP; Gupta MC; Kyrk CR; Kapoor H; Clark P; Schochetman G; Desai SM
    Clin Diagn Lab Immunol; 2004 Jul; 11(4):651-7. PubMed ID: 15242936
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative efficacies of three commercially available vaccines against West Nile Virus (WNV) in a short-duration challenge trial involving an equine WNV encephalitis model.
    Seino KK; Long MT; Gibbs EP; Bowen RA; Beachboard SE; Humphrey PP; Dixon MA; Bourgeois MA
    Clin Vaccine Immunol; 2007 Nov; 14(11):1465-71. PubMed ID: 17687109
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serologic response to West Nile virus vaccination in the greater one-horned rhinoceros (Rhinoceros unicornis).
    Wolf TM; Gandolf AR; Dooley JL; Atkinson MW; Wolfe BA
    J Zoo Wildl Med; 2008 Dec; 39(4):537-41. PubMed ID: 19110693
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pathogenicity of West Nile virus in chickens.
    Senne DA; Pedersen JC; Hutto DL; Taylor WD; Schmitt BJ; Panigrahy B
    Avian Dis; 2000; 44(3):642-9. PubMed ID: 11007013
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.